Genetic and functional analysis of the NKX2-5 gene promoter in patients with ventricular septal defects

Pediatric Cardiology

Volumn 33, Issue 8, 2012, Pages 1355-1361

  Pang, Shuchao ^a   Shan, Jiping ^a   Qiao, Yanli ^a   Ma, Liming ^a   Qin, Xianyun ^a   Wanyan, Hongxin ^a   Xing, Qining ^a   Wu, Guanghua ^a   Yan, Bo ^a  

^a JINING MEDICAL UNIVERSITY   (China)

Author keywords

NKX2 5; Promoter; Sequence variants; Ventricular septal defects

Indexed keywords

TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR NKX2.5; HOMEODOMAIN PROTEIN; NKX2 5 PROTEIN, HUMAN; NKX2-5 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADOLESCENT; ADULT; ARTICLE; CELL STRAIN HEK293; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; EXON; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENE REGULATORY NETWORK; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PROMOTER REGION; PROTEIN EXPRESSION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; GENETICS; HEART SEPTUM DEFECT; INFANT; MUTATION; POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; EXONS; FEMALE; HEART SEPTAL DEFECTS, VENTRICULAR; HOMEODOMAIN PROTEINS; HUMANS; INFANT; MALE; MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; SEQUENCE DELETION; TRANSCRIPTION FACTORS;

EID: 84878259638     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-012-0346-0     Document Type: Article

References (37)

1. Akazawa H, Komuro I (2005) Cardiac transcription factor Csx/Nkx2-5: its role in cardiac development and diseases. Pharmacol Ther 107:252-268 (Pubitemid 40910044)
2. Alappat S, Zhang ZY, Chen YP (2003) Msx homeobox gene family and craniofacial development. Cell Res 13:429-442 (Pubitemid 43231836)
3. Benson DW, Silberbach GM, Kavanaugh-McHugh A, Cottrill C, Zhang Y, Riggs S, Smalls O, Johnson MC, Watson MS, Seidman JG, Seidman CE, Plowden J, Kugler JD (1999) Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest 104:1567-1573 (Pubitemid 30002368)
4. Biben C, Weber R, Kesteven S, McDonald L, Elliott DA, Barnett L, Köentgen F, Robb L, Feneley M, Harvey RP (2000) Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ Res 87:888-895
5. Briggs LE, Takeda M, Cuadra AE, Wakimoto H, Marks MH, Walker AJ, Seki T, Oh SP, Lu JT, Sumners C, Raizada MK, Horikoshi N, Weinberg EO, Yasui K, Ikeda Y, Chien KR, Kasahara H (2008) Perinatal loss of Nkx2-5 results in rapid conduction and contraction defects. Circ Res 103:580-590
6. Bruneau BG (2008) The developmental genetics of congenital heart disease. Nature 451:943-948 (Pubitemid 351301750)
7. Chen CY, Schwartz RJ (1996) Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac alpha-actin gene transcription. Mol Cell Biol 16:6372-6384 (Pubitemid 26360996)
8. Dupays L, Jarry-Guichard T, Mazurais D, Calmels T, Izumo S, Gros D, Théveniau-Ruissy M (2005) Dysregulation of connexins and inactivation of NFATc1 in the cardiovascular system of NKX2-5 null mutants. J Mol Cell Cardiol 38:787-798 (Pubitemid 40591743)
9. Durocher D, Chen CY, Ardati A, Schwartz RJ, Nemer M (1996) The atrial natriuretic factor promoter is a downstream target for Nkx-2.5 in the myocardium. Mol Cell Biol 16:4648-4655 (Pubitemid 26272117)
10. Eckert D, Buhl S, Weber S, Jäger R, Schorle H (2005) The AP-2 family of transcription factors. Genome Biol 6:246 (Pubitemid 44725589)
11. Espinoza-Lewis RA, Liu H, Sun C, Chen C, Jiao K, Chen Y (2011) Ectopic expression of NKX2.5 suppresses the formation of the sinoatrial node in mice. Dev Biol 356:359-369
12. He A, Kong SW, Ma Q, Pu WT (2011) Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc Natl Acad Sci USA 108:5632-5637
13. Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, Nagai R, Komuro I (2001) Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet 28:276-280 (Pubitemid 32626032)
14. Hsu T, Trojanowska M, Watson DK (2004) Ets proteins in biological control and cancer. J Cell Biochem 91:896-903
15. Jay PY, Harris BS, Maguire CT, Buerger A, Wakimoto H, Tanaka M, Kupershmidt S, Roden DM, Schultheiss TM, O'Brien TX, Gourdie RG, Berul CI, Izumo S (2004) Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system. J Clin Invest 113:1130-1137 (Pubitemid 38544098)
16. Jay PY, Rozhitskaya O, Tarnavski O, Sherwood MC, Dorfman AL, Lu Y, Ueyama T, Izumo S (2005) Haploinsufficiency of the cardiac transcription factor Nkx2-5 variably affects the expression of putative target genes. FASEB J 19:1495-1497 (Pubitemid 41279009)
17. Lien CL, Wu C, Mercer B, Webb R, Richardson JA, Olson EN (1999) Control of early cardiac-specific transcription of Nkx2-5 by a GATA-dependent enhancer. Development 126:75-84 (Pubitemid 29045901)
18. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L, Harvey RP (1995) Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev 9:1654-1666
19. Pashmforoush M, Lu JT, Chen H, Amand TS, Kondo R, Pradervand S, Evans SM, Clark B, Feramisco JR, Giles W, Ho SY, Benson DW, Silberbach M, Shou W, Chien KR (2004) Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117:373-386 (Pubitemid 38534543)
20. Pierpont ME, Basson CT, Benson DW Jr, Gelb BD, Giglia TM, Goldmuntz E, McGee G, Sable CA, Srivastava D, Webb CL, American Heart Association Congenital Cardiac Defects Committee Council on Cardiovascular Disease in the Young (2007) Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 115:3015-3038 (Pubitemid 46912107)
21. Polager S, Ginsberg D (2008) E2F: at the crossroads of life and death. Trends Cell Biol 18:528-535
22. Przybylski GK, Dik WA, Grabarczyk P, Wanzeck J, Chudobska P, Jankowski K, von Bergh A, van Dongen JJ, Schmidt CA, Langerak AW (2006) The effect of a novel recombination between the homeobox gene NKX2-5 and the TRD locus in T-cell acute lymphoblastic leukemia on activation of the NKX2-5 gene. Haematologica 91:317-321
23. Reamon-Buettner SM, Borlak J (2010) NKX2-5: an update on this hypermutable homeodomain protein and its role in human congenital heart disease (CHD). Hum Mutat 31:1185-1194
24. Reecy JM, Li X, Yamada M, DeMayo FJ, Newman CS, Harvey RP, Schwartz RJ (1999) Identification of upstream regulatory regions in the heart-expressed homeobox gene Nkx2-5. Development 126:839-849 (Pubitemid 29106189)
25. Sauna ZE, Kimchi-Sarfaty C (2011) Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 12:683-691
26. Schlokat U, Bohmann D, Schöler H, Gruss P (1986) Nuclear factors binding specific sequences within the immunoglobulin enhancer interact differentially with other enhancer elements. EMBO J 5:3251-3258
27. Shiojima I, Oka T, Hiroi Y, Nagai R, Yazaki Y, Komuro I (2000) Transcriptional regulation of human cardiac homeobox gene CSX1. Biochem Biophys Res Commun 272:749-757 (Pubitemid 30420711)
28. Small EM, Krieg PA (2003) Transgenic analysis of the atrialnatriuretic factor (ANF) promoter: NKX2-5 and GATA-4 binding sites are required for atrial-specific expression of ANF. Dev Biol 261:116-131 (Pubitemid 36993822)
29. Stallmeyer B, Fenge H, Nowak-Göttl U, Schulze-Bahr E (2010) Mutational spectrum in the cardiac transcription factor gene NKX2.5 (CSX) associated with congenital heart disease. Clin Genet 78:533-540
30. Takeuchi JK, Lou X, Alexander JM, Sugizaki H, Delgado-Olguín P, Holloway AK, Mori AD, Wylie JN, Munson C, Zhu Y, Zhou YQ, Yeh RF, Henkelman RM, Harvey RP, Metzger D, Chambon P, Stainier DY, Pollard KS, Scott IC, Bruneau BG (2011) Chromatin remodelling complex dosage modulates transcription factor function in heart development. Nat Commun 2:187
31. Tanaka M, Wechsler SB, Lee IW, Yamasaki N, Lawitts JA, Izumo S (1999) Complex modular cis-acting elements regulate expression of the cardiac-specifying homeobox gene Csx/Nkx2.5. Development 126:1439-1450 (Pubitemid 29195233)
32. Terada R, Warren S, Lu JT, Chien KR, Wessels A, Kasahara H (2011) Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation. Cardiovasc Res 91:289-299
33. Toko H, Zhu W, Takimoto E, Shiojima I, Hiroi Y, Zou Y, Oka T, Akazawa H, Mizukami M, Sakamoto M, Terasaki F, Kitaura Y, Takano H, Nagai T, Nagai R, Komuro I (2002) Csx/Nkx2-5 is required for homeostasis and survival of cardiac myocytes in the adult heart. J Biol Chem 277:24735-24743 (Pubitemid 34952005)
34. van der Bom T, Zomer AC, Zwinderman AH, Meijboom FJ, Bouma BJ, Mulder BJ (2011) The changing epidemiology of congenital heart disease. Nat Rev Cardiol 8:50-60
35. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP, Vliegen HW, Grobbee DE, Mulder BJ (2010) Mortality in adult congenital heart disease. Eur Heart J 31:1220-1229
36. Vincentz JW, Barnes RM, Firulli BA, Conway SJ, Firulli AB (2008) Cooperative interaction of NKX2.5 and Mef2c transcription factors during heart development. Dev Dyn 237:3809-3819
37. Zhang MQ (2007) Computational analyses of eukaryotic promoters. BMC Bioinform 8(Suppl 6):S3 (Pubitemid 351833851)